Navigation Links
Fujirebio Diagnostics Appoints Grady Barnes as Chief Scientific Officer
Date:3/23/2009

et up in July 2005 to combine Fujirebio Inc., the leading in-vitro diagnostics company, and SRL, Inc., the top provider of clinical laboratory testing services in Japan. Fujirebio Diagnostics has a worldwide distribution network which enables physicians and patients to access its diagnostic products. For more information about Fujirebio Diagnostics, please call

610-240-3800 or visit www.fdi.com.


'/>"/>
SOURCE JFK Communications, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Fujirebio Diagnostics and Roche Diagnostics Sign Agreement for New Ovarian Cancer Test
2. Fujirebio Diagnostics and Abbott Agree To Develop New Ovarian Cancer Test for Abbotts Architect(R) Analyzers
3. Quest Diagnostics to Speak at the Bear Stearns Healthcare Conference
4. Pathway Diagnostics Announces Commercial Availability of SensiTrop(TM) HIV Co-receptor Tropism Assay
5. Hypertension Diagnostics Announces Fiscal Year 2007 Results
6. Foundation Venture Capital Group, LLC Invests in Start Up Committed to Breast Cancer Diagnostics
7. Meretek Diagnostics and Otsuka America Pharmaceutical, Inc. Announce Completion of Merger
8. Siemens Medical Solutions Diagnostics Announces the Release of the Rapidlab 1200 Series Version 2.0 Software
9. Virginia G. Piper Charitable Trust and Flinn Foundation launch molecular diagnostics initiative
10. HealthShares(TM) Announces Changes to the HealthShares(TM) Diagnostics and Composite Indexes
11. Optherion Licenses Worldwide Rights to Develop Age-Related Macular Degeneration Diagnostics Based on Chromosome 10 Genetic Variations

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)....,Nov.25 /PRNewswire-FirstCall/-- TheProvidenceS...itsLogistiCaresubsidiary,thenation,slargestcoordin...receivednoticeofawardfromtheStateofFloridaCommissi...idnon-emergencytransportationservicestobothMiami-D...14millioninrevenueovertheinitial18monthterm,issubj...
(Date:11/25/2009)...rovidesFinancialFlexibility,AllowingCompanytoAcces...5/PRNewswire-FirstCall/-LabopharmInc.(TSX:DDS;NASD...uitydistributionagreement(SEDA)withYAGlobalMasterS...etermsoftheagreement,YAhascommittedtoprovideupto$2...rm,sdiscretion,throughthepurchaseofnewlyissuedLabo...
(Date:11/25/2009)...change by reducing carbon dioxide and other greenh...its in addition to reducing the risk of climate ch...g to a series of six papers appearing today (Wed.,... Two University of California, Berkeley, authors o...environmental health, and Michael Jerrett, associa...
(Date:11/25/2009)... Thirty-seven million Americans are afflicte...nvasive technology for treating chronic sinus infl... Jackson, Miss. The Balloon Sinuplasty™ syst...alloon to quickly open and expand blocked sinuses....009 -- A clinically proven, minimally invasive tec...
(Date:11/25/2009)... Beginning Today through Sunday, November 29...memory foam and latex sofa bed mattress + an addit...nd a 100 night money back guarantee. Use the code ...take advantage of this special offer. , ...ns of Americans will travel from Thanksgiving thro...
Breaking Medicine News(10 mins):Health News:Providence Service Corporation's LogistiCare Subsidiary Announces Non-Emergency Medical Transportation Contracts Worth Over $11 Million Annually in Florida 2Health News:Providence Service Corporation's LogistiCare Subsidiary Announces Non-Emergency Medical Transportation Contracts Worth Over $11 Million Annually in Florida 3Health News:Labopharm Enters Into CAD$25 Million Standby Equity Distribution Agreement 2Health News:Labopharm Enters Into CAD$25 Million Standby Equity Distribution Agreement 3Health News:Cutting greenhouse pollutants could directly save millions of lives worldwide 2Health News:Cutting greenhouse pollutants could directly save millions of lives worldwide 3Health News:Novel Technology in Treating Chronic Sinus Infections Available at Baptist 2Health News:Novel Technology in Treating Chronic Sinus Infections Available at Baptist 3Health News:Providing Comfort for Holiday Guests Just Got Easier 2Health News:Providing Comfort for Holiday Guests Just Got Easier 3
...nd Specialty Pharmacy programs expand URAC,s Pharm..., Oct. 28 URAC announced that four,companies have...mail,programs under its Pharmacy Quality Managemen...am of,this scope for the pharmacy benefit manageme...
...esterol-lowering statins is associated with a stat... antigen (PSA) levels, according to a report in th...ational Cancer Institute . , Previous studies exa...ned the association between statins and PSA level....
...., Oct. 28 Dean Barkley,candidate for US Senate f...mprehensive strategy to fight HIV/AIDS in the US a...orm Coleman and other candidates from,Minnesota wi...ed to take a bold stand on this issue.", Barkley ...
...s, Oct. 28 Animal Health,International, Inc. (Nas...,release financial results for its fiscal year 200...y, November 4, 2008. Animal Health,International, ...the conference call by dialing (719) 785-1758.,Par...
...e of the ED drug delayed disease progression, rese...thDay News) -- Cialis (tadalafil), a drug used to ...reating pulmonary hypertension, researchers report... become tired, dizzy and short of breath, because ...
...Oct. 28 WellPoint, Inc. (NYSE:,WLP) announced tod...at the,following conferences:, -- Oppenheimer 19t...,at 2:00 p.m. Eastern Standard Time ("EST"); and, ...invited to listen to webcasts of the,presentations...
Other Medicine News:Health News:Four Companies Are First to Achieve Accreditation Under Two New URAC Pharmacy Quality Management(SM) Programs 2Health News:Statin use associated with reduction in prostate specific antigen levels 2Health News:Senator Dean Barkley Pledges Action on HIV/AIDS Epidemic 2Health News:Cialis May Help Ease Pulmonary Hypertension 2Health News:WellPoint Announces Appearances at Upcoming Conferences 2
(Date:11/25/2009)...ov.25/PRNewswire/--AccordingtoMillenniumResearchGr...etintelligence,thenearly$3billionUSmarketfortrauma...nextfiveyearsdespitetherecenteconomicslowdown.MRG,...hismarketwillremainhighlydynamicoverthenextfiveyea...reviouslyunderservedsegmentsofthetraumafixationmar...
(Date:11/25/2009)...,Nov.25/PRNewswire/--CempraPharmaceuticalsInc.toda...efexecutiveofficer,willpresentatthePiperJaffray21s...,2009,atTheNewYorkPalaceHotelinNewYorkCity.Dr.Fern...antibioticclinicalprogramsforthetreatmentofdrug-re...harmaceuticals ,, Foundedin2006,CempraPharmace...
(Date:11/25/2009)...PRNewswire/--Reportlinker.comannouncesthatanewmark...IntranasalDrugDelivery-USMarketTrends&Analysis...Drug-Delivery---US-Market-Trends--Analysis.html ,...anexpansionoftherapeuticapplicationsfromthedeliver...fsystemictherapeuticdrugs.Thefutureofthetechnology...
Breaking Medicine Technology:US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5French Physicians to Conduct 2000 Patient Study of CATANIA 28TM 29 Coronary Stent 14671 1French Physicians to Conduct 2000 Patient Study of CATANIA 28TM 29 Coronary Stent 14671 2Shire Reports Tolerability and Clinical Effects Results of Daytrana 28R 29 28methylphenidate transdermal system 29 from Study in Adolescents with ADH 5890 1Shire Reports Tolerability and Clinical Effects Results of Daytrana 28R 29 28methylphenidate transdermal system 29 from Study in Adolescents with ADH 5890 2Shire Reports Tolerability and Clinical Effects Results of Daytrana 28R 29 28methylphenidate transdermal system 29 from Study in Adolescents with ADH 5890 3Shire Reports Tolerability and Clinical Effects Results of Daytrana 28R 29 28methylphenidate transdermal system 29 from Study in Adolescents with ADH 5890 4Shire Reports Tolerability and Clinical Effects Results of Daytrana 28R 29 28methylphenidate transdermal system 29 from Study in Adolescents with ADH 5890 5Shire Reports Tolerability and Clinical Effects Results of Daytrana 28R 29 28methylphenidate transdermal system 29 from Study in Adolescents with ADH 5890 6Shire Reports Tolerability and Clinical Effects Results of Daytrana 28R 29 28methylphenidate transdermal system 29 from Study in Adolescents with ADH 5890 7Antibiotic Resistance Still a Major Public Health Threat 60427 1Antibiotic Resistance Still a Major Public Health Threat 60427 2Antibiotic Resistance Still a Major Public Health Threat 60427 3Antibiotic Resistance Still a Major Public Health Threat 60427 4
....--(BUSINESS WIRE)--Apr 30, 2007 - CollaGenex,Phar...at a new,report in the May 2007 issue of the Journ...ng two randomized phase III clinical trials,demon...ry dose,doxycycline (Oracea(R), 40-mg doxycycline,...report has concluded these studies,establish the f...
...A--(BUSINESS WIRE)--Apr 30, 2007 - Hemispherx Biop...scientific publication,(Journal of Immunology, Apr...erties of its proprietary experimental therapeutic...anded RNA being,tested as a monotherapy for Chroni...gs and vaccines., The new peer-reviewed study show...
Other Medicine Technology:Evaluating the Efficacy and Safety of Once-Daily Anti-Inflammatory,Dose Doxycycline for the Treatment of Rosacea 2Evaluating the Efficacy and Safety of Once-Daily Anti-Inflammatory,Dose Doxycycline for the Treatment of Rosacea 3Evaluating the Efficacy and Safety of Once-Daily Anti-Inflammatory,Dose Doxycycline for the Treatment of Rosacea 4New Report Illuminates Ampligen's Unique Mechanism of Action 2New Report Illuminates Ampligen's Unique Mechanism of Action 3New Report Illuminates Ampligen's Unique Mechanism of Action 4
Tensiobag
...ilEyes CTR is a device designed for permanent impl...ct removal surgery. It provides secondary capsular...s. The CTR is a uniplanar, 270-degree, semi-circle...ing polymethylmethacrylate (PMMA) with one manipul...
Hannum Ronguer/Grasper
Cobra Retractors
Medicine Products: